Wedelolactone Mitigates Parkinsonism Via Alleviating Oxidative Stress and Mitochondrial Dysfunction Through NRF2/SKN-1

C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging

Tjakko J. van Ham, Karen L. Thijssen, Rainer Breitling et al. · PLoS Genetics · 2008 · 426 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson’s disease: Involvement of mitochondrial dysfunctions and oxidative stress

Rajib Paul, Amarendranath Choudhury, Sanjeev Kumar et al. · PLoS ONE · 2017 · 88 citations · Full text

Life Sciences, Neurology, Neuroscience +17

RETRACTED: Enhancing Chemosensitivity of Breast Cancer Stem Cells by Downregulating SOX2 and ABCG2 Using Wedelolactone-encapsulated Nanoparticles

Sreemanti Das, Pritha Mukherjee, Ranodeep Chatterjee et al. · Molecular Cancer Therapeutics · 2018 · 78 citations

Pharmacy, Oncology, Pharmacology +17

State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease

Sneha Mantri, Michelle Fullard, James C. Beck et al. · npj Parkinson s Disease · 2019 · 73 citations · Full text

Public Affairs, Geriatric Medicine, Health Services Research +15

Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway

Jinyu Yang, Lijun Tao, Bei Liu et al. · Frontiers in Pharmacology · 2019 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17